Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,361 active trials259 approved drugs3,860 evidence items
- NCIt
- C7062
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,753 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05839834 | Blood Cell RNA-Based Cancer Detection(eRBCDet) | unknown | — | 5,000 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT05883683 | Molecular Study and Precision Medicine for Colorectal Cancer(MSPM) | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 1 |
| Jul 24, 2024 |
| clinicaltrials |
| NCT06237491 | The Safety and Dosimetry Study of 177Lu-LNC1003 Injection | unknown | Phase 1 | 12 | Yantai LNC Biotechnology Singapore PTE. LTD.INDUSTRY | 0 | Jul 24, 2024 | clinicaltrials |
| NCT06256055 | Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors | unknown | Phase 1 | 24 | UTC Therapeutics Inc.INDUSTRY | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06479460 | Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients | unknown | — | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06516445 | SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC | unknown | Phase 2 | 33 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06517992 | Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)(Communicated) | unknown | N/A | 80 | Gadjah Mada UniversityOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT04503148 | Anesthesia and Cancer Study: Renal Cell Carcinoma | unknown | N/A | 562 | Seoul National University HospitalOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT04739618 | Metastatic Solid Cancer Clinical Trial | unknown | Phase 2 | 32 | ImmunSYS, LLCOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT05921812 | Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients | unknown | — | 70 | Sohag UniversityOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06109207 | Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas | unknown | Phase 1 | 6 | West China HospitalOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06263387 | Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine(VENAZA) | unknown | — | 230 | French Innovative Leukemia OrganisationOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06516276 | Technologies to Improve QoL of Prostate Cancer(MIO) | unknown | N/A | 98 | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaOTHER | 0 | Jul 23, 2024 | clinicaltrials |
| NCT05013099 | Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies(iPREDICT) | unknown | Phase 2 | 70 | ImaginAb, Inc.INDUSTRY | 6 | Jul 22, 2024 | clinicaltrials |
| NCT05731752 | Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 80 | Hangzhou Hanx Biopharmaceuticals, Ltd.INDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT05776693 | Relationships Among Physical and Psychological Status, Social Support, Resource Utilization, Supportive Care Needs in Patients With Gynecological Cancer | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT05987345 | Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer | unknown | N/A | 10 | Energenx Medical LTD.INDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06331455 | Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection(SUPER) | unknown | Phase 2 | 12 | Marc de PerrotOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06512272 | Video-recOrded hospItal dischaRge (VOIR)(VOIR) | unknown | N/A | 60 | Anglia Ruskin UniversityOTHER | 0 | Jul 22, 2024 | clinicaltrials |
| NCT06512428 | A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 138 | Shanghai Runshi Pharmaceutical Technology Co., LtdINDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06512610 | ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML | unknown | — | 100 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06512896 | Clinical Study on Intraluminal Injection of FOLactis | unknown | N/A | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06513481 | A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery(E-DISTANCE) | unknown | — | 914 | RenJi HospitalOTHER | 0 | Jul 22, 2024 | clinicaltrials |
| NCT03362801 | SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly(SAMPHYR) | unknown | N/A | 69 | University Hospital, CaenOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06509529 | The Effect of Motivational Interviewing Based on the COM-B Model | unknown | N/A | 68 | Ordu UniversityOTHER | 0 | Jul 19, 2024 | clinicaltrials |
| NCT06510127 | An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study | unknown | — | 840 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT03614689 | Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire | unknown | — | 104 | Geneplus-Beijing Co. Ltd.INDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT04303988 | A Phase II Study of Triple-negative Breast Cancer Brain Metastases. | unknown | Phase 2 | 35 | Fudan UniversityOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT04847505 | 68Ga-DOTA-TATE PET/CT Imaging in NETs | unknown | Phase 3 | 5,000 | Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05837429 | Low Volume High Intensity Interval Training in Operated Lung Cancer Patients | unknown | N/A | 40 | Hacettepe UniversityOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT06508684 | Current Status of BTKi Treatment for CLL/SLL in China | unknown | — | 1,000 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT04318730 | Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma | unknown | Phase 2 | 21 | West China HospitalOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT04712877 | Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers | unknown | — | 1,000 | Lung Cancer Mutation ConsortiumNETWORK | 1 | Jul 17, 2024 | clinicaltrials |
| NCT06058858 | Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis(CMV CAR-T) | unknown | — | 250 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT06142071 | Mixed Methods Study to Assess Family Members Unmet Needs in an Oncology Setting(SALUTE) | unknown | — | 50 | Swansea Bay University Health BoardOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT06505486 | GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC | unknown | — | 21 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT05183243 | GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results | unknown | Phase 1 | 68 | Suzhou Genhouse Bio Co., Ltd.OTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT05271292 | Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.(SCLC) | unknown | Phase 1 / Phase 2 | 36 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06502210 | Identification of New Gene Spliceosomes in Neuroblastoma | unknown | — | 20 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06502704 | Bile Acids and Microbiome in Early Colorectal Carcinogenesis | unknown | — | 60 | Vilnius UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06503042 | A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC | unknown | — | 100 | Tang-Du HospitalOTHER | 0 | Jul 16, 2024 | clinicaltrials |
| NCT06503094 | CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors | unknown | Phase 1 / Phase 2 | 80 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06503211 | On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma | unknown | Phase 1 | 10 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06504017 | FUS-TB VS COG-TB in Small Lesions of Prostate Cancer | unknown | N/A | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Jul 16, 2024 | clinicaltrials |
| NCT01456429 | Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.(ASTER2) | unknown | N/A | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 2 | Jul 15, 2024 | clinicaltrials |
| NCT04798820 | The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)(SING) | unknown | N/A | 358 | Samsung Medical CenterOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06497686 | The Application of Rapid Fresh Digital Pathology on the Diagnosis and Biomarker Testing of Lung Cancer | unknown | — | 300 | National Taiwan University HospitalOTHER | 0 | Jul 15, 2024 | clinicaltrials |
| NCT06501261 | CALM Psychotherapy in Patients With Metastatic Cancer in Chile(CALM-Ch) | unknown | N/A | 34 | Fundacion Arturo Lopez PerezOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06497777 | The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer | unknown | — | 30 | National Taiwan University HospitalOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT06499142 | STP.168 Clinical Study Protocol Parakeet(Parakeet) | unknown | N/A | 60 | Neurovision Medical Products IncINDUSTRY | 1 | Jul 12, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Jul 24, 2024source: clinicaltrials